
The $30 Billion Question: Can Cannabis Pouches Do What Zyn Did For Nicotine?
THC pouches could rival the $30B chew market, says economist Beau Whitneyâbut only if pricing, regulation and adoption fall into place.
THC pouches could rival the $30B chew market, says economist Beau Whitneyâbut only if pricing, regulation and adoption fall into place.
Doug Kass says most cannabis stocks are âwalking dead' â but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors.
After cannabis healed their rift, Los Arias and his father launched Flostar Group. Now he's speaking at Benzinga's June conference.
LEEF soared 25% on a new deal with Glass House. Here's what else moved markets in cannabis after earnings from CWBHF, AFCG, and GLASF.
The U.S. cannabis industry lost 3.4% of its jobs in 2024 despite $30.1B in sales. Vangst's new report shows where the market is growingâand why.
Pepe Mujica, the first president to legalize recreational cannabis, has died at 89. His legacy shaped drug policy worldwide.
Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.
Dr. Chanda Macias lost her home to open a dispensary. Now, as Queen Zulu, she inspires a movementâincluding Brittney Griner.
This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.